This is a time of rapid change in psychiatry, with the introduction of DSM V, new treatments, and new treatment guidelines. Some of these changes have generated controversy: are the changes in DSM V supported by research?; do new medications and brain stimulation treatments lead to better outcomes?; are generic medications reliable?
UCLA's 18th Annual Review of Psychiatry and Psychopharmacology Update will address the most controversial questions in mental health treatment today. Our expert faculty will review the latest studies that can help shape your treatment decisions. The conference will take place on Friday, October 11 and Saturday, October 12, 2013 at The Skirball Cultural Center in Los Angeles. Leaders in the field of mental health will be sharing their expertise on diagnosis and treatment of depression, schizophrenia, ADHD, addiction, and bipolar disorder.
Course Chair: Andrew F. Leuchter, M.D.
At the end of this activity, participants will be able to:
- review the changes in DSM V, and how this manual will change practice
- compare the efficacy and side effects of typical and atypical antipsychotic medications
- perform accurate differential diagnosis of psychotic disorders in young adult populations
- assess and treat negative symptoms in schizophrenia effectively
- review the behavioral symptoms and treatment of Alzheimer's disease
- consider guidelines for duration of long term use for insomnia medications
- differentiate between the classes of mood stabilizers and their clinical uses
- utilize the latest treatments for a variety of psychiatric disorders, including schizophrenia, ADHD, insomnia, and autism